HENRIQUES, Luila Clicia Moura et al.
 Cost-effectiveness analysis of prophylaxis with emicizumab or bypassing agents in children with severe haemophilia A and high-response inhibitors after immunotolerance failure in Brazil.
<strong>Medical Research Archives</strong>, [S.l.], v. 13, n. 5, may 2025.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/6546" target="_new">https://esmed.org/MRA/mra/article/view/6546</a>&gt;. Date accessed: 12 june 2025.
doi: <a href="https://doi.org/10.18103/mra.v13i5.6546">https://doi.org/10.18103/mra.v13i5.6546</a>.